Home
AI Agent
Annotations
Files

Pricing and plans
Get the full experience
We save the real magic for signed-in users.

Home Stock Screener Document Search Charting Watchlists Recent Filings

Oruka Therapeutics, Inc.(ORKA US)

$105.35+0.360.34%Ext:$106.82+1.471.39%(Market Closed · 00:58:46 UTC)

Doc Search Profile Entity StructureFinancials Charting Short Interest Employees

Overview

Profile Entity Structure

Documents

Categorized Chronological By Owner

Financials & Metrics

Financials Charting Short Interest Employees

Home
AI Agent
Annotations
Files

Pricing and plans
Get the full experience
We save the real magic for signed-in users.

Home Stock Screener Document Search Charting Watchlists Recent Filings

Oruka Therapeutics, Inc.(ORKA US)

$105.35+0.360.34%Ext:$106.82+1.471.39%(Market Closed · 00:58:46 UTC)

Doc Search Profile Entity StructureFinancials Charting Short Interest Employees

Overview

Profile Entity Structure

Documents

Categorized Chronological By Owner

Financials & Metrics

Financials Charting Short Interest Employees

ORKA US

ORKA US

SEC Filings

SEC Filings

Financials(122)

10-QQ3ended 30 Sept 20269 Nov
10-QQ2ended 30 Jun 202610 Aug
10-QQ1ended 31 Mar 202613 May
10-KFY 2025ended 31 Dec 202512 Mar
10-QQ3ended 30 Sept 202512 Nov 2025
10-QQ2ended 30 Jun 202511 Aug 2025
10-KFY 2024ended 31 Dec 20246 Mar 2025
10-QQ3ended 30 Sept 202413 Nov 2024
10-QQ2ended 30 Jun 20241 Aug 2024
10-QQ1ended 31 Mar 202425 Apr 2024
10-KFY 2023ended 31 Dec 20231 Feb 2024
10-QQ3ended 30 Sept 202318 Oct 2023
10-QQ2ended 30 Jun 202321 Jul 2023
10-QQ1ended 31 Mar 202324 Apr 2023
10-KFY 2022ended 31 Dec 202224 Feb 2023

Events(395)

8-KPRESS RELEASE, DATED OCTOBER 26, 202626 Oct
8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers24 Aug
8-KPRESS RELEASE, DATED AUGUST 10, 202610 Aug
8-KSubmission of Matters to a Vote of Security Holders4 Jun
8-KOther Events1 Jun
8-KEXCERPT FROM PRELIMINARY PROSPECTUS SUPPLEMENT DATED APRIL 27, 202630 Apr
8-KPRESS RELEASE, DATED APRIL 27, 202627 Apr
8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers11 Dec 2025
8-KPRESS RELEASE, DATED SEPTEMBER 17, 202522 Sep 2025
8-KDirector/Officer Changes & Compensatory Arrangements1 Jul 2025
8-KSubmission of Matters to Shareholder Vote3 Jun 2025
8-KEntry into Material Agreement5 Feb 2025
8-KEntry into Material Agreement19 Dec 2024
8-KSubmission of Matters to Shareholder Vote18 Nov 2024
8-KAUDITED FINANCIAL STATEMENT OF ORUKA THERAPEUTICS, INC. AS OF FEBRUARY 6, 202414 Nov 2024

Insider Ownership(458)

Form 4Agarwal Arjun13 Nov
Form 4BALL KRISTINE M13 Nov
Form 4Klein Lawrence Otto2 Nov
Form 4Quinlan Paul T20 Oct
Form 4Goncalves Joana15 Oct
Form 4Agarwal Arjun13 Oct
Form 4Klein Lawrence Otto2 Oct
Form 4Agarwal Arjun21 Sep
Form 4Quinlan Paul T21 Sep
Form 4Goncalves Joana15 Sep
Form 4Agarwal Arjun15 Sep
Form 4Klein Lawrence Otto15 Sep
Form 4Quinlan Paul T15 Sep
Form 4Sandler Laura Lee15 Sep
Form 4Sandler Laura Lee1 Sep

Beneficial Ownership(148)

SC 13G/AOruka Therapeutics, Inc.14 Aug
SC 13G/AOruka Therapeutics, Inc.14 Aug
SC 13GOruka Therapeutics, Inc.14 Aug
SC 13GOruka Therapeutics, Inc.12 Aug
SC 13D/AOruka Therapeutics, Inc.1 Jul
SC 13G/AOruka Therapeutics, Inc.15 May
SC 13D/AOruka Therapeutics, Inc.4 May
SC 13G/AOruka Therapeutics, Inc.27 Mar
SC 13G/AOruka Therapeutics, Inc.17 Feb
SC 13G/AOruka Therapeutics, Inc.13 Feb
SC 13GOruka Therapeutics, Inc.30 Jan
SC 13GOruka Therapeutics, Inc.21 Jan
SC 13G/AOruka Therapeutics, Inc.14 Nov 2025
SC 13G/AOruka Therapeutics, Inc.17 Oct 2025
SC 13GOruka Therapeutics, Inc.24 Sep 2025

Other Ownership(20)

Form 144Agarwal Arjun12 Nov
Form 144BALL KRISTINE M12 Nov
Form 144Klein Lawrence Otto2 Nov
Form 144Goncalves Joana15 Oct
Form 144Agarwal Arjun13 Oct
Form 144Klein Lawrence Otto1 Oct
Form 144Agarwal Arjun21 Sep
Form 144Sandler Laura Lee1 Sep
Form 144Klein Lawrence Otto1 Sep
Form 144Quinlan Paul T14 Aug
Form 144Goncalves Joana15 Jul
Form 144Agarwal Arjun13 Jul
Form 144Fairmount Funds Management LLC1 Jul
Form 144Dambkowski Carl11 Jun
Form 144Dambkowski Carl21 May

Proxies(71)

ARSANNUAL REPORT17 Apr
DEFA14APROXY STATEMENT17 Apr
DEF 14APROXY STATEMENT17 Apr
DEFA14ADEFINITIVE ADDITIONAL MATERIALS18 Apr 2025
DEF 14APROXY STATEMENT18 Apr 2025
ARSANNUAL REPORT18 Apr 2025
DEF 14ADefinitive proxy statement18 Oct 2024
PRE 14APreliminary proxy statement7 Oct 2024
ARSAnnual report to security holders24 Jul 2024
DEF 14ADefinitive proxy statement19 Dec 2023
ARSAnnual report to security holders19 Dec 2023
DEFA14ADefinitive additional materials19 Dec 2023
DEF 14ADefinitive proxy statement3 Nov 2022
DEFA14ADefinitive additional materials3 Nov 2022
DEFA14ADefinitive additional materials28 Jun 2021

Registrations(237)

424B5PROSPECTUS28 Aug
S-3REGISTRATION STATEMENT21 Aug
424B5PROSPECTUS SUPPLEMENT29 Apr
424B5PRELIMINARY PROSPECTUS SUPPLEMENT27 Apr
424B5PRELIMINARY PROSPECTUS SUPPLEMENT27 Apr
424B7PROSPECTUS SUPPLEMENT21 Apr
S-3REGISTRATION STATEMENT2 Apr
S-8REGISTRATION STATEMENT12 Mar
424B3PROSPECTUS5 Nov 2025
424B5PROSPECTUS5 Nov 2025
S-3/AAMENDMENT NO. 1 TO FORM S-314 Oct 2025
S-3/AAMENDMENT NO. 1 TO FORM S-314 Oct 2025
S-3REGISTRATION STATEMENT3 Oct 2025
S-3REGISTRATION STATEMENT3 Oct 2025
424B3PROSPECTUS SUPPLEMENT22 Sep 2025

Filing Review Correspondence(15)

CORRESPFiling review correspondence8 Apr
CORRESPFiling review correspondence22 Nov 2024
CORRESPFiling review correspondence23 Jul 2024
CORRESPFiling review correspondence22 Jul 2024
CORRESPFiling review correspondence9 Jul 2024
CORRESPFiling review correspondence18 Jun 2024
CORRESPFiling review correspondence26 Mar 2021
CORRESPFiling review correspondence18 May 2020
CORRESPFiling review correspondence10 May 2017
CORRESPFiling review correspondence10 May 2017
CORRESPFiling review correspondence8 May 2017
CORRESPFiling review correspondence16 Jul 2015
UPLOADFiling review upload22 Dec 2010
CORRESPFiling review correspondence21 Dec 2010
UPLOADFiling review upload10 Dec 2010

SEC Orders And Notices(40)

EFFECTNotice of effectiveness28 Aug
EFFECTNotice of effectiveness13 Apr
EFFECTNotice of effectiveness11 Mar 2025
EFFECTNotice of effectiveness26 Nov 2024
EFFECTNotice of effectiveness24 Jul 2024
EFFECTNotice of effectiveness30 Mar 2021
EFFECTNotice of effectiveness20 May 2020
CT ORDERConfidential treatment order17 May 2019
CT ORDERConfidential treatment order10 May 2018
CT ORDERConfidential treatment order13 Dec 2017
EFFECTNotice of effectiveness12 May 2017
CT ORDERConfidential treatment order14 Apr 2017
CT ORDERConfidential treatment order14 Sep 2016
CT ORDERConfidential treatment order1 Mar 2016
EFFECTNotice of effectiveness26 Oct 2015

Exempt Offerings(8)

D06b25 Jun 2015
D06b20 Feb 2014
DNotice of exempt offering of securities (Reg D)17 Jun 2013
DNotice of exempt offering of securities (Reg D)1 Feb 2013
DNotice of exempt offering of securities (Reg D)28 Dec 2012
DNotice of exempt offering of securities (Reg D)31 Oct 2012
DNotice of exempt offering of securities (Reg D)5 Jan 2012
DNotice of exempt offering of securities (Reg D)26 Oct 2009

Other(5)

SEC STAFF LETTERSEC STAFF LETTER26 Jul 2024
SEC STAFF LETTERSEC STAFF LETTER12 Jul 2024
10-K40510-K40520 Mar 2000
10-K40510-K40522 Mar 1999
10-K40510-K40531 Mar 1998

Financials(122)

10-QQ3ended 30 Sept 20269 Nov
10-QQ2ended 30 Jun 202610 Aug
10-QQ1ended 31 Mar 202613 May
10-KFY 2025ended 31 Dec 202512 Mar
10-QQ3ended 30 Sept 202512 Nov 2025
10-QQ2ended 30 Jun 202511 Aug 2025
10-KFY 2024ended 31 Dec 20246 Mar 2025
10-QQ3ended 30 Sept 202413 Nov 2024
10-QQ2ended 30 Jun 20241 Aug 2024
10-QQ1ended 31 Mar 202425 Apr 2024
10-KFY 2023ended 31 Dec 20231 Feb 2024
10-QQ3ended 30 Sept 202318 Oct 2023
10-QQ2ended 30 Jun 202321 Jul 2023
10-QQ1ended 31 Mar 202324 Apr 2023
10-KFY 2022ended 31 Dec 202224 Feb 2023

Events(395)

8-KPRESS RELEASE, DATED OCTOBER 26, 202626 Oct
8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers24 Aug
8-KPRESS RELEASE, DATED AUGUST 10, 202610 Aug
8-KSubmission of Matters to a Vote of Security Holders4 Jun
8-KOther Events1 Jun
8-KEXCERPT FROM PRELIMINARY PROSPECTUS SUPPLEMENT DATED APRIL 27, 202630 Apr
8-KPRESS RELEASE, DATED APRIL 27, 202627 Apr
8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers11 Dec 2025
8-KPRESS RELEASE, DATED SEPTEMBER 17, 202522 Sep 2025
8-KDirector/Officer Changes & Compensatory Arrangements1 Jul 2025
8-KSubmission of Matters to Shareholder Vote3 Jun 2025
8-KEntry into Material Agreement5 Feb 2025
8-KEntry into Material Agreement19 Dec 2024
8-KSubmission of Matters to Shareholder Vote18 Nov 2024
8-KAUDITED FINANCIAL STATEMENT OF ORUKA THERAPEUTICS, INC. AS OF FEBRUARY 6, 202414 Nov 2024

Insider Ownership(458)

Form 4Agarwal Arjun13 Nov
Form 4BALL KRISTINE M13 Nov
Form 4Klein Lawrence Otto2 Nov
Form 4Quinlan Paul T20 Oct
Form 4Goncalves Joana15 Oct
Form 4Agarwal Arjun13 Oct
Form 4Klein Lawrence Otto2 Oct
Form 4Agarwal Arjun21 Sep
Form 4Quinlan Paul T21 Sep
Form 4Goncalves Joana15 Sep
Form 4Agarwal Arjun15 Sep
Form 4Klein Lawrence Otto15 Sep
Form 4Quinlan Paul T15 Sep
Form 4Sandler Laura Lee15 Sep
Form 4Sandler Laura Lee1 Sep

Beneficial Ownership(148)

SC 13G/AOruka Therapeutics, Inc.14 Aug
SC 13G/AOruka Therapeutics, Inc.14 Aug
SC 13GOruka Therapeutics, Inc.14 Aug
SC 13GOruka Therapeutics, Inc.12 Aug
SC 13D/AOruka Therapeutics, Inc.1 Jul
SC 13G/AOruka Therapeutics, Inc.15 May
SC 13D/AOruka Therapeutics, Inc.4 May
SC 13G/AOruka Therapeutics, Inc.27 Mar
SC 13G/AOruka Therapeutics, Inc.17 Feb
SC 13G/AOruka Therapeutics, Inc.13 Feb
SC 13GOruka Therapeutics, Inc.30 Jan
SC 13GOruka Therapeutics, Inc.21 Jan
SC 13G/AOruka Therapeutics, Inc.14 Nov 2025
SC 13G/AOruka Therapeutics, Inc.17 Oct 2025
SC 13GOruka Therapeutics, Inc.24 Sep 2025

Other Ownership(20)

Form 144Agarwal Arjun12 Nov
Form 144BALL KRISTINE M12 Nov
Form 144Klein Lawrence Otto2 Nov
Form 144Goncalves Joana15 Oct
Form 144Agarwal Arjun13 Oct
Form 144Klein Lawrence Otto1 Oct
Form 144Agarwal Arjun21 Sep
Form 144Sandler Laura Lee1 Sep
Form 144Klein Lawrence Otto1 Sep
Form 144Quinlan Paul T14 Aug
Form 144Goncalves Joana15 Jul
Form 144Agarwal Arjun13 Jul
Form 144Fairmount Funds Management LLC1 Jul
Form 144Dambkowski Carl11 Jun
Form 144Dambkowski Carl21 May

Proxies(71)

ARSANNUAL REPORT17 Apr
DEFA14APROXY STATEMENT17 Apr
DEF 14APROXY STATEMENT17 Apr
DEFA14ADEFINITIVE ADDITIONAL MATERIALS18 Apr 2025
DEF 14APROXY STATEMENT18 Apr 2025
ARSANNUAL REPORT18 Apr 2025
DEF 14ADefinitive proxy statement18 Oct 2024
PRE 14APreliminary proxy statement7 Oct 2024
ARSAnnual report to security holders24 Jul 2024
DEF 14ADefinitive proxy statement19 Dec 2023
ARSAnnual report to security holders19 Dec 2023
DEFA14ADefinitive additional materials19 Dec 2023
DEF 14ADefinitive proxy statement3 Nov 2022
DEFA14ADefinitive additional materials3 Nov 2022
DEFA14ADefinitive additional materials28 Jun 2021

Registrations(237)

424B5PROSPECTUS28 Aug
S-3REGISTRATION STATEMENT21 Aug
424B5PROSPECTUS SUPPLEMENT29 Apr
424B5PRELIMINARY PROSPECTUS SUPPLEMENT27 Apr
424B5PRELIMINARY PROSPECTUS SUPPLEMENT27 Apr
424B7PROSPECTUS SUPPLEMENT21 Apr
S-3REGISTRATION STATEMENT2 Apr
S-8REGISTRATION STATEMENT12 Mar
424B3PROSPECTUS5 Nov 2025
424B5PROSPECTUS5 Nov 2025
S-3/AAMENDMENT NO. 1 TO FORM S-314 Oct 2025
S-3/AAMENDMENT NO. 1 TO FORM S-314 Oct 2025
S-3REGISTRATION STATEMENT3 Oct 2025
S-3REGISTRATION STATEMENT3 Oct 2025
424B3PROSPECTUS SUPPLEMENT22 Sep 2025

Filing Review Correspondence(15)

CORRESPFiling review correspondence8 Apr
CORRESPFiling review correspondence22 Nov 2024
CORRESPFiling review correspondence23 Jul 2024
CORRESPFiling review correspondence22 Jul 2024
CORRESPFiling review correspondence9 Jul 2024
CORRESPFiling review correspondence18 Jun 2024
CORRESPFiling review correspondence26 Mar 2021
CORRESPFiling review correspondence18 May 2020
CORRESPFiling review correspondence10 May 2017
CORRESPFiling review correspondence10 May 2017
CORRESPFiling review correspondence8 May 2017
CORRESPFiling review correspondence16 Jul 2015
UPLOADFiling review upload22 Dec 2010
CORRESPFiling review correspondence21 Dec 2010
UPLOADFiling review upload10 Dec 2010

SEC Orders And Notices(40)

EFFECTNotice of effectiveness28 Aug
EFFECTNotice of effectiveness13 Apr
EFFECTNotice of effectiveness11 Mar 2025
EFFECTNotice of effectiveness26 Nov 2024
EFFECTNotice of effectiveness24 Jul 2024
EFFECTNotice of effectiveness30 Mar 2021
EFFECTNotice of effectiveness20 May 2020
CT ORDERConfidential treatment order17 May 2019
CT ORDERConfidential treatment order10 May 2018
CT ORDERConfidential treatment order13 Dec 2017
EFFECTNotice of effectiveness12 May 2017
CT ORDERConfidential treatment order14 Apr 2017
CT ORDERConfidential treatment order14 Sep 2016
CT ORDERConfidential treatment order1 Mar 2016
EFFECTNotice of effectiveness26 Oct 2015

Exempt Offerings(8)

D06b25 Jun 2015
D06b20 Feb 2014
DNotice of exempt offering of securities (Reg D)17 Jun 2013
DNotice of exempt offering of securities (Reg D)1 Feb 2013
DNotice of exempt offering of securities (Reg D)28 Dec 2012
DNotice of exempt offering of securities (Reg D)31 Oct 2012
DNotice of exempt offering of securities (Reg D)5 Jan 2012
DNotice of exempt offering of securities (Reg D)26 Oct 2009

Other(5)

SEC STAFF LETTERSEC STAFF LETTER26 Jul 2024
SEC STAFF LETTERSEC STAFF LETTER12 Jul 2024
10-K40510-K40520 Mar 2000
10-K40510-K40522 Mar 1999
10-K40510-K40531 Mar 1998